News

Article November 27, 2023

CRISPR-Powered ‘Cancer Shredding’ Technique Opens New Possibility for Treating Most Common and Deadly Brain Cancer

Gladstone Institutes researchers leveraged CRISPR to target and rapidly destroy glioblastoma cells in an approach that could carry over to other highly mutated cancers

News Release Research (Publication) Cancer Doudna Lab CRISPR/Gene Editing

Gladstone in the News November 23, 2023

Inside Long COVID’s War on the Body: Researchers Are Trying to Find Out Whether the Virus Has the Potential to Cause Cancer

Fortune—Researchers are investigating the possibility that people who suffer from Long COVID might be at elevated risk of developing cancer. Melanie Ott, director of the Gladstone Institute of Virology, explains that viruses related to SARS-CoV-2 have been shown to inactivate oncosuppressor proteins, which may predispose patients to cancer.

Gladstone Experts Cancer COVID-19 Virology Ott Lab

Article November 20, 2023

Gladstone Mourns the Loss of Longtime Trustee Albert Dorman

Dorman served as a Gladstone trustee for over 30 years

History Profile

Article November 17, 2023

Enchanted by the Earliest Stages of Human Life

Magdalena Zernicka-Goetz, recipient of the 2023 Ogawa-Yamanaka Stem Cell Prize, has created self-assembling embryo-like models that are advancing regenerative medicine

Awards Ogawa Stem Cell Prize Profile Stem Cells/iPSCs

Article November 14, 2023

Meet Gladstone: Christina Buselli

Research Associate Christina Buselli describes her work in the Finkbeiner lab, her path to science, and the questions she wishes she could ask her grandfather

Profile Finkbeiner Lab

Article November 13, 2023

How Good Can Overpower Evil in the Genetic Determination of Alzheimer’s Disease

New research sheds light on protective mechanisms of the “Christchurch mutation”

News Release Research (Publication) Alzheimer’s Disease Center for Translational Advancement Neurological Disease Huang Lab

Article November 13, 2023

American Heart Association Honors Gladstone President Deepak Srivastava with Distinguished Scientist Award

The award recognizes leaders who have made major contributions to the fields of cardiovascular and stroke science

Awards News Release Cardiovascular Disease Srivastava Lab

Article November 9, 2023

New Tool Unsnarls DNA-Winding Mystery, with Likely Implications for Many Diseases

A novel method developed by Gladstone researchers is already answering longstanding questions about basic DNA dynamics—and may one day lead to new ways of treating cancer and other conditions

News Release Research (Publication) Data Science and Biotechnology Ramani Lab Big Data

Gladstone in the News November 7, 2023

Special Episode: JAHA Distinguished Hearts and Minds Roundtable

AHA with JAHA Podcast—In a roundtable forum, the American Heart Association’s 2023 Distinguished Scientists describe their contributions to stroke and cardiovascular research. Gladstone President Deepak Srivastava discusses the use of human iPS cells in drug discovery and his hopes for the future of science and medicine, including applications of artificial intelligence.

Gladstone Experts Congenital Heart Disease Cardiovascular Disease Srivastava Lab Human Genetics Stem Cells/iPSCs

Article October 20, 2023

Study on Largest Genetic Risk Factor for Alzheimer’s Points Toward New Drug Target

Gladstone researchers discovered how the ApoE4 gene variant makes neurons release an inflammatory signaling molecule—and how blocking that release could prevent or treat Alzheimer’s disease

News Release Research (Publication) Alzheimer’s Disease Neurological Disease Huang Lab

Article October 16, 2023

Where Biology and Open-Source Coding Converge

Software developers and their mentors at Gladstone help advance research through Google Summer of Code

Bioinformatics Core Data Science and Biotechnology Big Data Pico

Article October 13, 2023

Celebrating Latinx Voices at Gladstone

A time to reflect on the challenges and triumphs in STEM for the Latinx community

Diversity Profile

Article October 6, 2023

The Risk and the Reward

How the Dolby family works to improve outcomes for people with Alzheimer’s disease

Donor Stories Alzheimer’s Disease

Gladstone in the News October 3, 2023

New Paper Points the Way to Make CRISPR Safer by Avoiding Chromosome Loss

Innovative Genomics Institute—Gladstone Senior Investigator Jennifer Doudna and Affiliate Investigator Jimmie Ye, along with collaborators at the Parker Institute for Cancer Immunology and Stanford, have discovered a way to increase the safety of CRISPR editing by preventing chromosome loss, a toxic side-effect of the technology in some cells.

Gladstone Experts Cancer Data Science and Biotechnology Parker Institute for Cancer Immunotherapy Doudna Lab Ye Lab CRISPR/Gene Editing

Article October 3, 2023

A Quarter Century of Disease-Focused Neuroscience

Celebrating 25 years of neurological disease research at Gladstone

History Institutional News News Release Neurological Disease